Systematic Reviews
Copyright ©The Author(s) 2017.
World J Gastroenterol. Feb 21, 2017; 23(7): 1298-1309
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1298
Table 3 General recommendations and questions for future research
General recommendations:
Identify prevalence of psychological conditions based upon standardized and validated assessment tools (e.g., SCID[37], MINI[38])
Use standardized assessment of gastroparesis (e.g., gastric emptying scintigraphy, PAGI-SYM[39])
Use validated psychological scales to assess, anxiety, depression, stress (e.g., BDI[40], BAI[41], STAI[42], DASS[43]) and QoL measures relevant to individuals with upper gastrointestinal disorders (e.g., PAGI-QoL[44])
Use and provide clear scoring information
Report assessment results in a manner that allows comparison across studies (e.g., standardized cut-off scores)
Psychological interventions:
Randomized control trial design
Prior to intervention, power analyses conducted
Clear details of intervention content made fully available to allow other researchers to review and undertake accurate replication
Gastroparesis-focused interventions
Include measures that assess a cost/benefit analysis, engagement of medical services
Where possible, patients, assessors, and statistician blinded
Independent evaluation of intervention session recordings to ensure protocol/treatment consistency
Psychological interventions need to be clearly identified and undertaken by trained and appropriately qualified individuals (i.e., psychologists, psychiatrists)
Identify clear inclusion and exclusion criteria
Identifying if (and where possible control for) participants have/have not received or are currently receiving psychotherapy (including type, duration etc.), using psychotropic medication, are on specialized diets for their gastroparesis
Utilize valid measures which can be accurately compared to other intervention studies
Evaluate participant engagement in therapy (e.g., % attendance to sessions, completion of homework)
Evaluate differences between completers versus non-completers
Include long-term post-therapy efficacy review time points (i.e., 1 and 2 yr post-intervention)
Future research questions:
What is the prevalence of psychopathology in gastroparesis compared to other gastroenterological cohorts?
What psychological processes act as moderating/mediating factors between gastroparesis symptom activity and outcome variables such as QoL, anxiety, and depression (e.g., personality, coping style, self-efficacy)?
How may gender impact upon the presentation and course of gastroparesis and associated psychological distress?
How may historical and current stressors and/or traumas impact upon the presentation and course of gastroparesis?
To what extent does duration of symptoms/disease influence the relationship between gastroparesis and psychological distress?